Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

African American living-kidney donors should be screened for APOL1 risk alleles.

Transplantation - 15 Oct 2011

Cohen David M, Mittalhenkle Anuja, Scott David L, Young Carlton J, Norman Douglas J

Abstract excerpt

The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Apolipoproteins
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Lipoproteins, HDL

Share to Living Donors

Source

Open in PubMed Open full text

Identifiers

PMID: 21878839
DOI: 10.1097/TP.0b013e31822eec39
PMCID: PMC4620991

Genes

APOL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

African American living-kidney donors should be screened for APOL1 risk alleles.PMID 21878839Read ↗

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.Semantic proximity Read ↗

Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.Semantic proximity Read ↗

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.Semantic proximity Read ↗

APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.Semantic proximity Read ↗

Apolipoprotein L1: role in the evaluation of kidney transplant donors.Semantic proximity Read ↗

The evolving science of apolipoprotein-L1 and kidney disease.Semantic proximity Read ↗

Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.Semantic proximity Read ↗

Apolipoprotein L1 and Kidney Disease in African Americans.Semantic proximity Read ↗

Apolipoprotein L1 Gene Effects on Kidney Transplantation.Semantic proximity Read ↗

The APOL1 gene and allograft survival after kidney transplantation.Semantic proximity Read ↗

Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.Semantic proximity Read ↗

APOL1 variants associate with increased risk of CKD among African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.